The Role of Financial Incentives in GP Practices
Getting a GP appointment can be a challenge, especially when you’re bombarded with messages from your surgery about overdue health checks or vaccinations. It might seem confusing that GPs are often so busy yet eager to see patients for specific tests or treatments. The reason behind this could be linked to financial incentives, which play a significant role in the funding of GP practices.
GP funding is derived from a variety of sources, including government allocations and other income streams. Some of these funds come with specific requirements, often set at a national level, which encourage certain activities. For instance, GPs may be incentivised to review patients on particular medications and switch them to more cost-effective alternatives.
Recent headlines have highlighted how NHS GP practices in England will receive up to £3,000 annually to increase prescriptions for obesity drugs like Mounjaro as part of a £25m initiative. This has sparked concerns that GPs might prioritise financial gain over patient care. However, experts like Professor Victoria Tzortziou Brown from the Royal College of GPs emphasize that clinical decisions are based on what is best for individual patients, not financial incentives.
How Financial Incentives Work
The UK Quality and Outcomes Framework (QOF), introduced in 2004, is one of the largest pay-for-performance programs in primary care. Initially, it included over 150 indicators and accounted for 20-25% of the income for many practices. Each year, practices are rewarded based on four quality domains: clinical, organisational, additional services, and patient experience. Achieving these indicators earns points, which are then converted into income depending on the size of the practice population and disease prevalence.
Incentive payments have been used to improve various aspects of healthcare, such as dementia care, vaccination rates, and statin prescribing. Over time, some indicators have been retired, and new ones added, reducing the proportion of income tied to QOF. NHS Scotland removed all QOF incentives in 2016 to reduce administrative burdens and focus on a more holistic approach to care.
Effectiveness of Incentivised Health Targets
Research suggests that incentive schemes can positively impact patient outcomes, but their effects may not last without continued financial motivation. A 2025 systematic review found that introducing QOF incentives led to an average 6.1% improvement in recorded quality of care after one year. However, this improvement was less consistent over three years, with small declines in non-incentivised care.
Withdrawal of incentives also resulted in a decline in quality of care, with average decreases of 10.7% and 12.8% after one and three years, respectively. This indicates that the success of pay-for-performance programs often depends on ongoing financial support.
Concerns Among GPs
Some GPs feel that incentive programs have eroded trust between patients and doctors. Dr Whyte, a GP in London, expresses frustration with the red tape and box-ticking exercises required by these schemes. He notes that patients may question whether treatments are being prescribed to meet targets rather than for their benefit.
There are also concerns about “crowding out” effects, where focusing on incentivised conditions may neglect other aspects of healthcare. For example, diabetes management under QOF may improve outcomes for those with comorbidities but worsen them for others.
Administrative requirements for GPs and staff can also be burdensome. While some practices use incentive payments to hire additional staff, others struggle with the financial reliance on these schemes.
Challenges and Future Directions
Despite these challenges, there are signs that ministers may be shifting away from incentive-based schemes. Recent GP contracts have allocated more funding to core budgets rather than QOF activity. Changes to the QOF for childhood vaccination indicators aim to reward practices in deprived areas that show meaningful improvement.
While these changes are positive, Dr Whyte believes the focus should be on GP recruitment to address the strain on practices. GPs want to spend more time treating patients rather than dealing with paperwork, and continued reforms to funding allocation are essential.
Financial incentives remain a complex issue, balancing the need for improved healthcare outcomes with the challenges of maintaining quality care and patient trust. As the system evolves, finding a sustainable model that supports both GPs and patients will be crucial.
